Back
ESC Professional Premium Access

Factors that increase the risk of hepatocarcinoma in Fontan-associated liver disease (FALD) and new biomarkers of FALD by proteomic analysis

Session: New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders
Topic: Congenital Heart Disease
Speaker: Doctor Y. Morimoto (Suita, JP)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Yoshihito Morimoto

National Cerebral & Cardiovascular Center, Suita (Japan)
1 follower

8 more presentations in this session

Discussant - Biomarkers, biomechanics, and innovations in valve and vascular disorders

Access
Like
Thumbnail

Benefits of extubation after the Fontan operation: a theoretical analysis using serial patient-specific Fontan computational fluid dynamics models

Speaker: Doctor K. Sughimoto (Chiba, JP)

Access
Abstract
Video
Like
Thumbnail

Patient vascular model reveals anti-inflammatory effects of SGLT2 inhibitor by modulating endothelial-T cell crosstalk

Speaker: Ms K. Lee (Singapore, SG)

Access
Abstract
Like
Thumbnail

Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis

Speaker: Doctor M. Al Zaidi (Bonn, DE)

Access
Abstract
Like
Thumbnail

A novel heart valve design reduces turbulence in aortic flow

Speaker: Doctor S. Zheng (Bern, CH)

Access
Abstract
Like
Thumbnail

Access the full session

New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders

Speakers: Doctor Y. Morimoto, Doctor K. Sughimoto, Ms K. Lee, Doctor M. Al Zaidi, Doctor S. Zheng
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources